Year: 1999
Type: review
Abstract: The need for safe and effective antifungal agents increases in parallel with the expanding number of immunocompromised patients at risk for invasive fungal infections. The emergence of fungal pathogens resistant to current therapies further compounds the dearth of antifungal agents. Currently
DOI: 10.1128/aac.43.1.1
Authors: Anthony J. De Lucca, Thomas J. Walsh
Language: English
Subfield: Microbiology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2896865833
